Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nosa Plugs | NOSA | May 31, 2024 | 0.52 | -2.80 |
Nosium | NOSIUMB | May 31, 2024 | 0.02 | -8.70 |
Note | NOTE | May 31, 2024 | 151.30 | -0.33 |
Novotek B | NTEKB | May 31, 2024 | 68.80 | 0.00 |
Novus Group | NOVU | May 31, 2024 | 3.14 | 0.00 |
Nowonomics | NOWO | May 31, 2024 | 3.88 | 0.00 |
NP3 Fastigheter | NP3 | May 31, 2024 | 248.50 | +1.22 |
NP3 Fastigheter Pref | NP3PREF | May 31, 2024 | 28.80 | -0.17 |
Nyfosa | NYF | May 31, 2024 | 106.70 | +2.50 |
Nykode Therapeutics | NYKDO | May 31, 2024 | 15.30 | 0.00 |
Obducat B | OBDUB | May 31, 2024 | 1.76 | +1.44 |
Observit | OBSE | May 31, 2024 | 0.16 | -2.28 |
ODI Pharma | ODI | May 31, 2024 | 7.25 | -2.68 |
Odinwell | ODIN | May 31, 2024 | 0.67 | +6.35 |
OEM International B | OEMB | May 31, 2024 | 125.00 | +1.13 |
Ogunsen B | OGUNB | May 31, 2024 | 38.30 | 0.00 |
OmniCar | OMNI | May 31, 2024 | 0.03 | +47.46 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | May 31, 2024 | 310.83 | +0.38 |
OMX NORDIC 40 | OMXN40 | May 31, 2024 | 2 861.91 | +0.85 |
OMX Oslo 20 GI | OMXO20GI | May 31, 2024 | 1 296.50 | +0.99 |
OMX Oslo 20 PI | OMXO20PI | May 31, 2024 | 729.11 | +0.99 |
OMX Stockholm 30 | OMXS30 | May 31, 2024 | 2 604.10 | +0.43 |
OMX Stockholm 30 GI | OMXS30GI | May 31, 2024 | 508.65 | +0.43 |
OMX Stockholm 60 Cap PI | OMXS60CAP | May 31, 2024 | 318.22 | +0.41 |
OMX Stockholm 60 PI | OMXS60PI | May 31, 2024 | 299.59 | +0.43 |
OMX Stockholm Automobiles & Parts PI | SX4010PI | May 31, 2024 | 1 635.99 | +2.18 |
OMX Stockholm Banks PI | SX3010PI | May 31, 2024 | 1 962.40 | +0.70 |
OMX Stockholm Basic Materials PI | SX55PI | May 31, 2024 | 2 798.44 | +0.42 |
OMX Stockholm Basic Resources PI | SX5510PI | May 31, 2024 | 2 633.07 | +0.42 |
OMX Stockholm Benchmark Cap GI | OMXSBCAPGI | May 31, 2024 | 2 301.35 | +0.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.